Clinical Trial Update: Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating efficacy and safety of rhGH (Jintropin) in pediatric participants with idiopathic short stature (ISS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dwarfism
• Idiopathic Short Stature

Drugs mentioned

• Jintropin (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Dwarfism | Phase 3 | Status: UNKNOWN